NCT00656357View on ClinicalTrials.gov

Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Cocaine Dependence
Interventions
DRUG

SYN117 Placebo

Placebo

DRUG

SYN117 80 mg

SYN117 80 mg

DRUG

SYN117 160 mg

SYN117 160 mg

DRUG

Cocaine 10mg

IV Cocaine 10mg

DRUG

Cocaine 20mg

IV Cocaine 20mg

DRUG

Cocaine 40mg

IV Cocaine 40mg

DRUG

Saline

IV Cocaine Placebo

Trial Locations (1)

77555

University of Texas Medical Branch (UTMB), Galveston

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Biotie Therapies Inc.

INDUSTRY

NCT00656357 - Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers | Biotech Hunter | Biotech Hunter